- Fund Type: Closed-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
H&Q Life Sciences Investors
+ Add to WatchlistXHQLX:US
18.24 USD 0.02 0.11%As of 09:29:30 ET on 05/24/2013.
Snapshot for H&Q Life Sciences Investors (XHQLX)
| Year To Date: | +26.27% | 3-Month: | +17.42% | 3-Year: | +28.75% | 52-Week Range: | 14.15 - 18.88 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +5.87% | 1-Year: | +35.76% | 5-Year: | +13.94% | Beta vs NBI: | 0.83 |
Fund Profile & Information for XHQLX
H&Q Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
| Inception Date: | 05-08-1992 | Telephone: | 1-617-772-8500 |
|---|---|---|---|
| Managers: | DANIEL R OMSTEAD | ||
| Web Site: | www.teklacap.com | ||
Fundamentals for XHQLX
| NAV | (on 2013-05-24) 18.24 |
|---|---|
| Assets (M) | (on 2013-05-24) 268.33 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | 0.00 |
Dividends for XHQLX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-05-23) 0.34 |
| Dividend Yield (ttm) | 6.85 |
Fees & Expenses for XHQLX
| Front Load | 0.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.98 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.00 |
| Expense Ratio | 1.72 |
Top Fund Holdings for XHQLX
Filing Date: 12/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | 100,799 | 17,243,685 | 7.893% |
| Gilead Sciences Inc | 464,770 | 17,068,678 | 7.813% |
| Celgene Corp | 179,377 | 14,120,558 | 6.464% |
| Biogen Idec Inc | 68,329 | 10,021,814 | 4.587% |
| Alexion Pharmaceuticals Inc | 99,214 | 9,307,265 | 4.260% |
| Mylan Inc/PA | 279,254 | 7,673,900 | 3.513% |
| Perrigo Co | 66,228 | 6,889,699 | 3.154% |
| Puma Biotechnology Inc | 342,757 | 6,426,694 | 2.942% |
| Hologic Inc | 251,589 | 5,039,328 | 2.307% |
| Vertex Pharmaceuticals Inc | 117,332 | 4,920,904 | 2.253% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page